-+ 0.00%
-+ 0.00%
-+ 0.00%

Datavault AI expands PharmacyChain blockchain licensing deal with DataMeds AI to broader healthcare uses

PUBT·07/29/2026 13:05:33
Listen to the news
Datavault AI expands PharmacyChain blockchain licensing deal with DataMeds AI to broader healthcare uses
  • Datavault AI expanded its PharmacyChain technology licensing deal with DataMeds AI to cover unencumbered commercial healthcare, healthspan, wellness applications.
  • Amended terms shift consideration to common shares equal to about 19.9% of DataMeds stock at closing, replacing preferred shares for tax optimization.
  • Closing remains tied to DataMeds completing related acquisitions, including two QOLPOM IP portfolios from EOS Technology Holdings.
  • Partnership targets patient-controlled healthcare data monetization, credentialing, blockchain-based data transactions, real-world asset tokenization across pharmacy, medical, lab, wearables settings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260729708218) on July 29, 2026, and is solely responsible for the information contained therein.